UA117672C2 - Антибактеріальні сполуки - Google Patents

Антибактеріальні сполуки

Info

Publication number
UA117672C2
UA117672C2 UAA201507312A UAA201507312A UA117672C2 UA 117672 C2 UA117672 C2 UA 117672C2 UA A201507312 A UAA201507312 A UA A201507312A UA A201507312 A UAA201507312 A UA A201507312A UA 117672 C2 UA117672 C2 UA 117672C2
Authority
UA
Ukraine
Prior art keywords
antibacterial compounds
compounds
relates
medicaments
integers
Prior art date
Application number
UAA201507312A
Other languages
English (en)
Inventor
Жером Еміль Жорж Гійємон
Магалі Мадлен Сімон Мотт
Аніл Коул
Насер Луні
Original Assignee
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47519922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA117672(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі filed Critical ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі
Publication of UA117672C2 publication Critical patent/UA117672C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Даний винахід стосується наступних сполук: EMBED ISISServer , (І) де цілі числа визначені в описі. Даний винахід також стосується застосування таких сполук для лікування бактеріальної інфекції, фармацевтичної композиції, що містить такі сполуки та способів їх одержання.
UAA201507312A 2012-12-21 2013-12-20 Антибактеріальні сполуки UA117672C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199026 2012-12-21
PCT/EP2013/077565 WO2014096300A2 (en) 2012-12-21 2013-12-20 Antibacterial compounds

Publications (1)

Publication Number Publication Date
UA117672C2 true UA117672C2 (uk) 2018-09-10

Family

ID=47519922

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201507312A UA117672C2 (uk) 2012-12-21 2013-12-20 Антибактеріальні сполуки

Country Status (21)

Country Link
US (3) US9428474B2 (uk)
EP (1) EP2934498B1 (uk)
JP (1) JP6441229B2 (uk)
KR (1) KR102233199B1 (uk)
CN (1) CN104981238B (uk)
AP (1) AP2015008503A0 (uk)
AU (1) AU2013366572B2 (uk)
BR (1) BR112015014145B1 (uk)
CA (1) CA2892899C (uk)
CL (1) CL2015001781A1 (uk)
EA (1) EA038333B1 (uk)
ES (1) ES2659953T3 (uk)
MX (1) MX381179B (uk)
MY (1) MY173280A (uk)
NZ (1) NZ708742A (uk)
PE (1) PE20151165A1 (uk)
PH (1) PH12015501428A1 (uk)
SA (1) SA515360628B1 (uk)
SG (1) SG11201504873RA (uk)
UA (1) UA117672C2 (uk)
WO (1) WO2014096300A2 (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014096300A2 (en) * 2012-12-21 2014-06-26 Janssen R&D Ireland Antibacterial compounds
US9801909B2 (en) 2015-04-06 2017-10-31 The Penn State Research Foundation Compositions and methods for combating bacterial infections by killing persister cells with mitomycin C

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744970A (fr) 1969-01-28 1970-07-27 Lilly Co Eli Agents antiviraux et immuno-depresseurs
US4028374A (en) 1975-11-03 1977-06-07 Morton-Norwich Products, Inc. Antibacterial thiocyanatobenzothiazoles
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
AU3631500A (en) * 1999-03-19 2000-10-09 Du Pont Pharmaceuticals Company N-adamant-1-yl-n'-(4-chlorobenzothiazol-2-yl) urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
DK1527050T3 (da) 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
RU2348629C2 (ru) 2003-05-30 2009-03-10 Ф.Хоффманн-Ля Рош Аг Производные бензотиазола и их применение при лечении заболеваний, связанных с аденозиновыми a2a-рецепторами
WO2005023818A2 (en) 2003-09-10 2005-03-17 Gpc Biotech Ag Heterobicyclic compounds as pharmaceutically active agents
EP1680431A1 (en) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
WO2007140439A2 (en) 2006-05-31 2007-12-06 Abbott Laboratories Compounds as cannabinoid receptor ligands and uses thereof
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2014096300A2 (en) 2012-12-21 2014-06-26 Janssen R&D Ireland Antibacterial compounds

Also Published As

Publication number Publication date
AU2013366572A1 (en) 2015-06-04
PE20151165A1 (es) 2015-08-19
BR112015014145A2 (pt) 2017-07-11
SG11201504873RA (en) 2015-07-30
CL2015001781A1 (es) 2015-11-06
PH12015501428B1 (en) 2015-09-07
AP2015008503A0 (en) 2015-06-30
CN104981238A (zh) 2015-10-14
MX2015008036A (es) 2015-10-29
EA038333B1 (ru) 2021-08-11
EA201591192A1 (ru) 2015-11-30
JP6441229B2 (ja) 2018-12-19
CA2892899C (en) 2021-07-20
EP2934498A2 (en) 2015-10-28
HK1210954A1 (en) 2016-05-13
BR112015014145B1 (pt) 2020-12-29
MX381179B (es) 2025-03-12
KR20150099772A (ko) 2015-09-01
JP2016503776A (ja) 2016-02-08
ES2659953T3 (es) 2018-03-20
US9951032B2 (en) 2018-04-24
CA2892899A1 (en) 2014-06-26
EP2934498B1 (en) 2017-11-15
SA515360628B1 (ar) 2017-05-18
US20150344449A1 (en) 2015-12-03
US20160347728A1 (en) 2016-12-01
MY173280A (en) 2020-01-10
WO2014096300A2 (en) 2014-06-26
NZ708742A (en) 2020-06-26
US20170369457A1 (en) 2017-12-28
AU2013366572B2 (en) 2018-08-30
KR102233199B1 (ko) 2021-03-30
WO2014096300A3 (en) 2014-08-14
CN104981238B (zh) 2019-05-31
PH12015501428A1 (en) 2015-09-07
US9758497B2 (en) 2017-09-12
US9428474B2 (en) 2016-08-30

Similar Documents

Publication Publication Date Title
PH12015501385A1 (en) Autotaxin inhibitors
MY198204A (en) Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
PH12013500473A1 (en) Triazine-oxadiazoles
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12014501702A1 (en) Imidazopyrrolidinone compounds
PH12015501609A1 (en) Phenicol antibacterials
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MX367309B (es) Nuevos compuestos antibacterianos.
UA113151C2 (xx) Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу
EA201491581A1 (ru) Везикулярные композиции
MX363480B (es) Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
MX2015015251A (es) Derivados de la quinolona.
UA117672C2 (uk) Антибактеріальні сполуки
BR112015006220A2 (pt) agentes antibacterianos de tetrahidroquinolina tricíclica
EA201270547A1 (ru) Фармацевтическая композиция
WO2014006601A3 (en) Nanoparticle compositions of antibacterial compounds and other uses thereof
IN2014KN02584A (uk)
EA201390764A1 (ru) Фармацевтические композиции
UA108238C2 (xx) Антибактеріальна композиція
TR201110248A2 (tr) 3,7-Bis(2-hydroxyethyl) icaritin bileşeninin gribal enfeksiyon tedavisinde kullanımı.